Search Orphan Drug Designations and Approvals
-
Generic Name: | brivanib alaninate |
---|---|
Date Designated: | 03/18/2011 |
Orphan Designation: | Treatment of hepatocellular carcinoma |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 06/27/2014 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Bristol-Myers Squibb P. O. Box 4000 Princeton, New Jersey 08543 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-